Company profile: Proxeon
1.1 - Company Overview
Company description
- Provider of solutions addressing scientific and technical challenges in proteomics, leveraging multidisciplinary expertise across biology, physics, engineering and informatics, developed by scientists actively involved in proteomics research.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Proxeon
ePharma Solutions
HQ: United States
Website
- Description: Provider of e-clinical solutions that help sponsors, pharmaceutical companies, CROs, and investigator sites accelerate and improve clinical studies through better site selection, training, activation, and management. Offerings include Site Feasibility to find and activate qualified sites globally, and Rater and Patient Training to mitigate bias and variability, improving data quality and standardization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ePharma Solutions company profile →
SubjectWell
HQ: United States
Website
- Description: Provider of a clinical trials patient recruitment marketplace and services, connecting trials with millions of patients via targeted campaigns. Offerings include Guided Recruitment linking pre-qualified patients to study sites, Direct Connect for registration and pre-screening, a Virtual Waiting Room to engage patients until eligible, full-service Recruitment Agency support, and Brand Connect precision marketing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SubjectWell company profile →
Median Technologies
HQ: France
Website
- Description: Provider of medical imaging software and services for oncology clinical trials, cancer screening, and clinical practice, standardizing and automating the interpretation of medical images to optimize diagnosis of cancer patients and assessment of their response to therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Median Technologies company profile →
CTS Database
HQ: United States
Website
- Description: Provider of a clinical trial subject registry that preserves the privacy and security of research subjects while providing sponsors and investigators with crucial information.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CTS Database company profile →
Triomics
HQ: United States
Website
- Description: Provider of an oncology-focused generative AI platform for clinical trial matching. Offers OncoLLM to process clinical and genomic data; Prism for EHR-integrated trial matching; Harmony for EHR data curation for tumor registries and precision oncology; Symphony to streamline care via triage, identifying missing data, and pre-charting; and Clinical Navigators for clinical workflow integration, trial navigation, and registry engagement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Triomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Proxeon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Proxeon
2.2 - Growth funds investing in similar companies to Proxeon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Proxeon
4.2 - Public trading comparable groups for Proxeon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →